Volume 35, 8 Oktober 2004 10/2004
 
  SPOT ON

ANGELIQ (estradiol plus drospirenone) for "hormone replacement therapy"
Once again: does immunization against hepatitis B cause multiple sclerosis?

 
  QUALITY ASSESSMENT
 

Quality of captopril (e.g. LOPIRIN) products

 
  NEW ON THE MARKET
 

COX-2 inhibitor etoricoxib (ARCOXIA)
Antiepileptic pregabalin (LYRICA)
Racecadotril (TIORFAN): antidiarrhoic agent for children

 
  THERAPIES FROM A CRITICAL VIEW POINT
 

Ximelagatran (EXANTA): licensing in USA uncertain
Intravenous immunoglobulins in secondary progressive multiple sclerosis without benefit

 
  a-t READERS' QUESTIONS AND COMMENTS
 

Cinnamon (DIABETRUW) for diabetes mellitus?

 
  IN BRIEF
 

Vitamins without benefit in cancer prevention
Endometrial effects of long-term treatment with phytoestrogens

 
  CURRENT ADR NETWORK REPORT
 

Severe myopathy with long-acting nicotinic acid (NIASPAN)

 
  WITHDRAWAL FROM THE MARKET
 

Rofecoxib (VIOXX) phased out worldwide because of cardiovascular toxicity

 
© arznei-telegramm 10/2004